23rd Annual Discovery on Target is focused on Novel Drug Targets issue including:
- Deacetylase Inhibitors
- Next-Generation Histone
- Developing CRISPR-Based Therapies
- Strategies for Rare Diseases
- And Chromatin Remodelers
- Targeting Epigenetic Readers
- Targeting the Microbiome
- Targeting the Ubiquitin Proteasome System
- Antibodies Against Membrane
- GPCR-Based Drug Discovery - Part 1
- RNAi for Functional Genomics Screening
- Protein Targets - Part 1
- Targeting Ocular Disorders
- Gene Therapy Breakthroughs
- And Demethylases
- Targeting Histone Methyltransferases
- Kinase Inhibitor Discovery
- Targeting the Unfolded Protein Response
- Antibodies Against Membrane
- GPCR-Based Drug Discovery - Part 2
- New Frontiers in Gene Editing
- Protein Targets - Part 2
- Quantitative Systems Pharmacology
Who should Attend
Full time graduate students and PhD Candidates
